Comments

Arch Therapeutics

ARTHOTCQB
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$4.10
3.59703.92%
After Hours: Jan 26, 9:27 AM EDT
15 minutes delayed
Arch Therapeutics (ARTH) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Arch Therapeutics (OTC:ARTH) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Arch Therapeutics (ARTH)?

A

There have been no specific sales or earnings guidance reported for Arch Therapeutics in recent months.

Browse guidance and forecast on all stocks.